Intranasal fentanyl for pain in pediatric emergencies
Part of Bones, joints & muscles, Mental health, Pain clinical trials.
This study looks back at children who already received fentanyl nasal spray for pain in the emergency department. It aims to see how well this method worked for treating sudden pain in children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a child under 18 years old.
- You were treated in the pediatric emergency department at Strasbourg University Hospital.
- You received fentanyl through a nasal spray between August 1, 2022 and September 30, 2024.
- You (or your parent or guardian) did not say no to having your health information used for this research.
- You live in France.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different nasal spray pain medicines (sufentanil and ketamine) to see which works better and is safer for children with severe pain from injuries, like a broken arm or leg.
This trial compares giving fentanyl as a nasal spray versus an injection to help preterm babies during painful procedures like placing a central line, inserting a breathing tube, or a spinal tap. The goal is to see which method works better and is safer.
This trial tests a nebulized (inhaled mist) form of fentanyl in healthy volunteers to see how it works in the body. It is a first-in-human study of the drug given through a nebulizer, which might help people with acute pain in the future.
This study compares three different fast-acting pain medicines given through the nose or by mouth to children with a suspected broken arm or leg in the emergency room. The goal is to find which medicine works best for pain relief within the first hour.
This study tests a new way to give a nasal spray of fentanyl (a strong painkiller) to premature babies before their routine eye exams for ROP. It aims to see if this medicine reduces pain and discomfort during the exam better than current standard care.
This trial tests a special painkiller called sufentanil given as a nasal spray to children with sickle cell disease who are having a severe pain crisis. It aims to see if this nasal spray works better or as well as usual pain treatment to quickly reduce pain in the emergency room.
Hear when a new Musculoskeletal Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.